Author: Press Room

Caitlyn Pratt is an avid Aldi shopper, so much so that she crosses state lines a few times a month, driving 45 minutes from her home in Heavener, Oklahoma to the nearest Aldi in neighboring Arkansas. The distance doesn’t bother her if it means she can do these three things: Stay within budget for her household needs, skip Walmart, and most importantly, indulge in a fun little affordable treasure hunt in a place that Aldi superfans have dubbed the “aisle of shame.” Aldi, a privately-held German discount grocer that touts a Walmart-like sales pitch of everyday low prices, has operated…

Last updated: April 19, 2024 10:52 EDT | 3 min read Amidst the surging prices of Polkadot and Shiba Inu, BlockDAG is capturing the imagination of the cryptocurrency world with its groundbreaking potential for a 30,000x return on investment. As Polkadot advances its community engagement and Shiba Inu rides a wave of investor enthusiasm, BlockDAG distinguishes itself with a novel blend of blockchain security and Directed Acyclic Graph (DAG) scalability. This innovative approach is highlighted by a teaser for an upcoming keynote video shot from the moon, promising to elevate the project to unprecedented heights. As BlockDAG’s presale gathers momentum, it…

Nelson Peltz’s hedge fund, Trian Partners, is waging a $25 million war for Disney board seats.Trian was once the “most feared” activist hedge fund, but its power may be waning, The Journal reported.If the bid for control at Disney fails, the outlet noted it might be Trian’s last major proxy fight. Thanks for signing up! Access your favorite topics in a personalized feed while you’re on the go. download the app As Trian Partners — Nelson Peltz’s hedge fund — wages a multimillion-dollar proxy war over two Disney board seats, some wonder whether this is the last big fight for the 81-year-old…

In an October YouTube video, lifestyle creator Shelby Church talks about quitting Airbnb. Two minutes into the video, an animation of two seltzer cans appears on screen with the text: “This video is brought to you by Bubly.”This new ad structure that’s being incorporated into YouTube and TikTok videos could help generate passive revenue for creators.The company behind the advertisement, Rembrand, wanted to embed brands into videos in a way that supports creators but doesn’t annoy their audiences by interrupting the content.”We realized that there’s this problem with interruptive advertising,” Rembrand CMO Cory Treffiletti told Business Insider. “Everybody understands that…

Lam Research (NASDAQ:LRCX) is a global supplier of wafer fabrication equipment and services for the semiconductor industry. The company exclusively supplies TSV (Through-Silicon Via) etching equipment to High Bandwidth Memory (HBM) suppliers. Currently, I think the market hasn’t fully appreciated the growth potential of HBM-Driven DRAM. I initiate with a ‘Strong Buy’ rating with a one-year price target of $1,045. HBM-Driven DRAM Growth HBM has been wildly used in GPUs, providing high bandwidth memory for AI-related computing. Samsung Electronics (OTCPK:SSNLF) and SK Hynix are the two main suppliers for HBM products. In Q4 FY23, Samsung Electronics delivered record-high HBM sales,…

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The husband of Scotland’s former first minister Nicola Sturgeon has been charged in connection with allegations of the embezzlement of funds from the Scottish National party.Peter Murrell, the SNP’s former chief executive, was arrested earlier on Thursday, after having previously been arrested on April 5 last year as part of Operation Branchform, an investigation that has cast a shadow over the party that has governed Scotland for 17 years.Police Scotland confirmed that a 59-year-old man, who was taken into custody for questioning…

CIA Director Bill Burns on Thursday warned that unless US sends more military support, Ukraine could “lose” the war against Russia by the end of the year. His comments mark one of the starkest warnings to date from the Biden administration on the stakes in Ukraine as Congress debates whether to approve a long-delayed aid package to Kyiv. Just a month ago, Burns had warned in testimony before the Senate Intelligence Committee that if Congress did not move to authorize additional support — long hampered by conservative opposition in the House of Representatives — “Ukraine is likely to lose ground and probably significant ground in 2024.” But…

In a recent move that has caught the attention of investors, Domo, Inc. (NASDAQ:), a leader in prepackaged software services, has reported significant stock transactions by one of its top executives. Thayne Daren, the company’s Chief Technology Officer and Executive Vice President of Product, has sold a total of $412,093 worth of Class B Common Stock. The transactions, which took place over two consecutive days, involved the sale of 41,218 shares at a weighted average price between $9.331 and $9.39 on the first day, and 2,866 shares at a weighted average price between $9.59 and $9.605 on the following day.…

Investing.com– Most Asian currencies retreated on Thursday, while the dollar steadied from recent gains as markets sought more cues on U.S. interest rates from producer inflation and retail sales data due later in the day.  Regional currencies were still reeling from a stronger-than-expected U.S. print earlier this week, which ramped up bets that the Federal Reserve will take its time in reducing interest rates. Dollar steady as data dump comes before Fed meeting  The and steadied in Asian trade on Thursday after reversing some of their gains earlier this week. Focus was largely on more inflation cues from and data,…

Medicare expects it will spend more $550 million this year for the controversial anti-Alzheimer’s drug Leqembi and predicts the cost will skyrocket to $3.5 billion in 2025, according to Stat News. The program spent $5.7 billion on drugs such as Ozempic and Mounjaro in 2022, according to the Kaiser Family Foundation. These GLP-1 medications were designed to treat type 2 diabetes but increasingly have been used by those without the condition to lose weight. And these costs are likely to skyrocket in coming years. Medicare has agreed to loosen its rules for paying for some GLP-1 drugs if a patient…